As severe weather events increase in frequency and intensity across the U.S. and around the world, scientists and forecasters are seeking more effective weather-mapping programs. VOA’s Julie Taboh has more. Camera: Adam Greenbaum   Produced by: JulieTaboh/Adam Greenbaum   …

A study conducted by Britain’s Oxford University suggests COVID-19 can increase a person’s risk of developing a psychiatric disorder within three months of catching the virus. The study, published Monday in the Lancet Psychiatry Journal, indicates one in five surviving COVID-19 patients was found to be diagnosed with a mental disorder within 90 days of a positive coronavirus test. The researchers say that is about twice the normal rate. The most common disorders diagnosed were anxiety, depression and insomnia, while patients were also found to have significantly higher risks for …

Just hours after news of a breakthrough in the effort to develop a safe and effective COVID-19 vaccine, Brazil has halted late-stage clinical trials of another potential vaccine.   The country’s health regulator Anvisa announced Monday that it was pausing tests of CoronaVac, developed by Chinese pharmaceutical company Sinovac, after an “adverse, serious event” with a volunteer participant. The event occurred on October 29, but the statement did not go into any further details. The clinical trials in Brazil are being conducted by Sao Paulo-based research institute Butantan. Dimas Covas, the …

The U.S. Supreme Court is set to hear oral arguments Tuesday in a Republican effort to strike down the Affordable Care Act health care law.The hearing comes weeks after Justice Amy Coney Barrett joined the court, giving conservatives a 6-3 majority.At the center of the case is a requirement in the 2010 law for most people to have a minimum level of health insurance or face a financial penalty.  In a 2012 case, the Supreme Court ruled that provision was allowed on the basis that it represented a tax that Congress is allowed to levy.  In 2017, the Republican-controlled Congress and set the …

Brazil’s health regulator Anvisa suspended clinical trials of a Chinese firm’s coronavirus vaccine after an unspecified “adverse incident” involving a volunteer recipient late last month. Anvisa would only say such incidents could involve a death or serious disability resulting in hospitalization.  Anvisa’s action with the CoronaVac vaccine occurred the same day a rival, U.S. pharmaceutical company, Pfizer, announced its vaccine has shown 90 percent effectiveness. Word of Pfizer’s vaccine success sent global financial markets soaring. Both the Pfizer and the Chinese Sinovac vaccine are in Phase III trials, the last stage of testing before regulators give it clearance for public use. Brazil has the highest coronavirus tally in Latin America, with more than 5,664,000 confirmed cases and 162,397 deaths, according to the Johns Hopkins University and Medicine Coronavirus Resource Center.  …

U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.  The Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization. It’s a one-time treatment given through an IV.  The therapy is still undergoing additional testing to establish its safety and effectiveness. It is similar to a treatment President Donald Trump received …